[US] Market Analysis - 2026-03-19

Predictions Summary

Today’s US model signals leaned constructive on selective large caps, with 3 buy signals and 2 sell signals. Highest conviction was ACN (BUY, 0.86), supported by the strongest sentiment and momentum profile. COP (BUY, 0.68) and CMCSA (BUY, 0.62) also screened positive, though with more moderate conviction. On the bearish side, DHR (SELL, -0.41) and BMY (SELL, -0.31) ranked weaker, suggesting relative downside or underperformance risk versus the broader market.

Executed Trades

We executed all long-side signals:

• ACN: bought 89 shares @ $204.93 for approximately $18,238.77
• COP: bought 148 shares @ $125.71 for approximately $18,605.08
• CMCSA: bought 647 shares @ $29.05 for approximately $18,791.35

Total deployed capital was approximately $55,635.20 across three positions. No failed trades, and no signals were skipped.

Market Outlook

Near term, the book is positioned for continued strength in quality momentum names, with ACN as the primary alpha candidate. COP adds cyclical exposure and should benefit if energy stays supported above recent levels, while CMCSA offers a lower-priced value/momentum setup. The negative reads on DHR and BMY suggest maintaining caution in defensive healthcare pockets. Overall, the signal set implies a moderately bullish US equity bias into the next session, with best expected risk-adjusted performance concentrated in the top-conviction long: ACN.